Rigel Pharmaceuticals (RIGL) EBITDA Margin Growth (5y) (2015 - 2026)
Rigel Pharmaceuticals (RIGL) EBITDA Margin Growth (5y) (2015 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
| 10 |
Rigel Pharmaceuticals |
603.18 Mn |
456.49 Mn |
54.21 Mn |
| Date | Value |
|---|
| Mar 31, 2026 |
-3,133.00 |
| Dec 31, 2025 |
13,524.00 |
| Sep 30, 2025 |
11,586.00 |
| Jun 30, 2025 |
16,865.00 |
| Mar 31, 2025 |
-1,376.00 |
| Dec 31, 2024 |
14,149.00 |
| Sep 30, 2024 |
8,313.00 |
| Jun 30, 2024 |
20,626.00 |
| Mar 31, 2024 |
12,199.00 |
| Dec 31, 2023 |
-120.00 |
| Sep 30, 2023 |
48,505.00 |
| Jun 30, 2023 |
144,157.00 |
| Dec 31, 2022 |
-58,058.00 |
| Sep 30, 2022 |
190,177.00 |
| Mar 31, 2022 |
29,514.00 |
| Dec 31, 2021 |
42,129.00 |
| Sep 30, 2021 |
51,292.00 |
| Jun 30, 2021 |
10,913.00 |
| Mar 31, 2021 |
40,085.00 |
| Dec 31, 2020 |
4,727.00 |
